Dublin, June 02, 2020 (GLOBE NEWSWIRE) -- The "Global Viral Vector and Plasmid Manufacturing Market: Focus on Vector Type, Application, Disease, 5 Region's Data, 15 Countries' Data, Patent Landscape ...
Inovio Pharmaceuticals’ synthetic plasmid DNA-based dMAb ® monoclonal antibody (mAb) technology provided mice with complete protection from lethal challenge with multiple influenza A and B virus ...
DNA vaccines, wherein a new antigen is inserted into a validated vector, have tremendous potential for deployment in pandemic applications as they can be rapidly produced in a validated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback